A Regional Hub for Advanced Biopharmaceutical Manufacturing
Designed for export, built to international regulatory excellence
Building Iraq's First FDA-Compliant Biopharmaceutical Factory.
Rowad Al Ebtkar Co. Ltd for Pharmaceutical & Life Sciences is a national strategic initiative designed to establish a fully integrated, FDA-compliant biopharmaceutical ecosystem in Iraq. The project represents a transformative step toward pharmaceutical sovereignty, advanced manufacturing, and global market integration. Through world-class facilities, international partnerships, and strict regulatory compliance, the company positions Iraq as a trusted regional and global hub for advanced biopharmaceutical industries.
About Us
Rowad Al Ebtkar Co. Ltd for Pharmaceutical & Life Sciences is conceived as a flagship national project under the supervision of the Iraqi Ministry of Health. The project integrates research, development, manufacturing, quality control, and global export within a single FDA-compliant ecosystem. It is not merely an industrial zone, but a scientific, economic, and strategic bridge connecting Iraq with leading international regulatory, academic, and industrial institutions.
National Flagship Project
Led under the Iraqi Ministry of Health to deliver a world-class biopharma ecosystem.
Integrated FDA-Compliant Platform
Research, development, manufacturing, quality control, and export within one ecosystem linked to global partners.
Vision & Mission
Vision
To position Iraq as a regional and global hub for advanced biopharmaceutical manufacturing and innovation.
Mission
To localize advanced pharmaceutical technologies, build national scientific capacity, and establish a sustainable, knowledge-driven health economy that meets the highest international standards.
Capabilities
Advanced Biomanufacturing
Plasma-derivative products and complex biologics.
Human & Veterinary Vaccines
mRNA and protein subunit technologies.
Biologics & Biosimilars
Advanced therapeutic development and production.
Cell & Gene Therapies
Including CAR-T platform readiness.
Radiopharmaceuticals & Diagnostics
Advanced diagnostics and precision imaging.
National R&D Institutes
Research, development, and innovation centers.
Quality & Compliance
All facilities and operations comply fully with FDA, EMA, and cGMP standards. The City applies dual audit systems under national and international oversight, ensuring transparency, safety, and global market eligibility. Quality systems are designed to meet regulatory requirements from the first day of operation.
- Full compliance with FDA, EMA, and cGMP standards
- Dual audit systems with national and international oversight
- Transparency, safety, and export readiness built in
- Quality systems designed from day one of operation
All facilities and operations comply fully with FDA, EMA, and cGMP standards. The City applies dual audit systems under national and international oversight, ensuring transparency, safety, and global market eligibility. Quality systems are designed to meet regulatory requirements from the first day of operation.
Partnerships
The project is built on strategic partnerships with leading international organizations, including FDA, WHO, UNDP, UNIDO, NIH, CDC, and NHS. These partnerships support technology transfer, capacity building, regulatory alignment, and long-term sustainability.
Regulatory Alignment
Partnerships with FDA and WHO for compliance and safety.
UN Development Programs
UNDP and UNIDO support technology transfer and sustainability.
Research Collaboration
NIH and CDC partnerships for scientific capacity building.
Health Systems
NHS cooperation for standards, training, and long-term impact.
National Impact
Sustainability & CSR
Sustainability is embedded in all aspects of the project through green biopharma infrastructure, renewable energy use, and environmental management systems. Social responsibility initiatives include affordable medicine programs, public health awareness, and support for national cancer treatment efforts.
- Green biopharma infrastructure
- Renewable energy utilization
- Environmental management systems
- Affordable medicines and national cancer support
Sustainability & CSR
Sustainability is embedded in all aspects of the project through green biopharma infrastructure, renewable energy use, and environmental management systems. Social responsibility initiatives include affordable medicine programs, public health awareness, and support for national cancer treatment efforts.
Contact
Connect with our team to discuss partnerships, manufacturing, or regulatory collaboration.